US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Veradigm Inc

us-stock
To Invest in {{usstockname}}
us-stock
$6.86 -0.1039(-10.39%) MDRX at 09 Dec 2025 05:50 PM Health Information Services
Lowest Today 6.2
Highest Today 7.33
Today’s Open 6.98
Prev. Close 7.6
52 Week High 11.80
52 Week Low 3.00
Day’s Range: Low 6.2 High 7.33
52-Week Range: Low 3.00 High 11.80
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Institutional Holdings

Vanguard Explorer Value Inv 0.67

Hartford Small Cap Value Y 0.42

abrdn Healthcare Opportunities 0.31

BlackRock Credit Strategies Instl 0.31

NYLI VP Wellington Small Cap Initial 0.28

Royce Small-Cap Trust 0.14

Adirondack Small Cap 0.09

abrdn World Healthcare 0.08

Wellington CIF II Global Equities 0.06

Wellington Sm Cap Value Opportunities 0.06

BlackRock Global Equity Mkt Netrl Instl 0.05

Teachers Retirement System Of The State Of Kentucky 0.03

Sterling Capital Management LLC 0.03

Northern Small Cap Core I 0.02

NT Col Quality SC Val Fd- NL - 3 0.02

NT Quality SCC US Fund - L 0.01

NT Quality Small Cap Core 0.01

FNY Investment Advisers, LLC 0.01

Wellington Hedged Alpha Opportunities 0.01

Principal Global Multi-Strategy Instl 0.01

Acclivity Small Cap Value I 0.00

Humankind US Stock ETF 0.00

Evli Equity Factor Global IA 0.00

Fuller & Thaler Asset Management Inc 0.00

GAMMA Investing LLC 0.00

Huntington National Bank 0.00

Kennedy Capital Management Inc 0.00

Nisa Investment Advisors, L.L.C. 0.00

Virginia Retirement Systems Et AL 0.00

Market Status

Strong Buy: 1

Buy: 0

Hold: 2

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 515.85 M

PB Ratio 0.507

PE Ratio 0.0

Enterprise Value 288.70 M

Total Assets 1504.72 M

Volume 81920717

Company Financials

Annual Revenue FY21:1503000000 1503.0M, FY20:1502700000 1502.7M, FY19:1771700000 1771.7M, FY18:1750000000 1750.0M, FY17:1806300000 1806.3M

Annual Profit FY21:619600000 619.6M, FY20:565695000 565.7M, FY19:713600000 713.6M, FY18:724600000 724.6M, FY17:782100000 782.1M

Annual Net worth FY21:134400000 134.4M, FY20:-132619000 -132.6M, FY19:-182600000 -182.6M, FY18:363700000 363.7M, FY17:-196500000 -196.5M

Quarterly Revenue Q3/2022:151900000 151.9M, Q2/2022:150900000 150.9M, Q1/2022:142700000 142.7M, Q4/2021:391700000 391.7M, Q3/2021:369200000 369.2M

Quarterly Profit Q3/2022:83400000 83.4M, Q2/2022:79500000 79.5M, Q1/2022:73500000 73.5M, Q4/2021:169000000 169.0M, Q3/2021:148800000 148.8M

Quarterly Net worth Q3/2022:11000000 11.0M, Q2/2022:3200000 3.2M, Q1/2022:22900000 22.9M, Q4/2021:87300000 87.3M, Q3/2021:16100000 16.1M

Fund house & investment objective

Company Information Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Organisation Health Information Services

Employees 2450

Industry Health Information Services

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right